Spotlight On... French CRO Porsolt buys a preclinical R&D firm; FDA launches new informatics platform; and much more...

Porsolt, a French contract drug researcher, bought a company focused on discovery-stage services. Acquiring the Bordeaux-headquartered Fluofarma, Porsolt is adding more capacity in cell-based assays, in vitro screening and other technology to pad its existing offerings in preclinical development. Release

> The FDA met its deadline of launching precisionFDA before year's end, unveiling its new informatics platform. News

> Indian drugmaker Sun Pharma is reportedly looking to buy local rival Intas Pharmaceuticals for $2.3 billion. Story

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.